Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country's ...

In response to rising demand for its popular diabetes and weight loss drug duo Mounjaro and Zepbound, Lilly has invested heavily to boost manufacturing capacity. With $27B plan to build 4 new ...

“Once I was stabilised I was too embarrassed to say I was on Mounjaro.” Mounjaro maker Lilly said: “Patient safety is Lilly’s top priority and we actively monitor, evaluate, and report ...

It has an agreement with Eli Lilly to sell, promote and distribute the American drugmaker's pharmaceutical portfolio in sub-Saharan Africa, including Mounjaro in South Africa, which became ...

Of course, Lilly's most important new products are diabetes treatment Mounjaro and weight management medicine Zepbound, which share the active ingredient tirzepatide. In 2024, Eli Lilly's revenue ...

The marketing push underscores Lilly’s efforts to further define itself as a reliable developer and distributor of its approved weight loss drugs — Mounjaro and Zepbound — by contrasting them to ...

Eli Lilly is investing an additional $27 billion to boost domestic drug production as President Donald Trump reaffirms his commitment to imposing tariffs to restore manufacturing in the U.S. The ...

(CNN) — Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the ...

Scott Disick faced those Mounjaro rumors head on when he admitted to using the weight loss drug. “It shows the Mounjaro? You’re lying!” Scott told Khloé, 40, when she called with the news.

including the popular weight-loss drug Mounjaro. Eli Lilly said the investment will create 3,000 high-skilled positions and approximately 10,000 construction jobs. Eli Lilly has unveiled plans to ...

Lilly’s tirzepatide drugs, Zepbound for obesity and Mounjaro for diabetes, both of which are administered by injection, accounted for $5.4 billion in revenue in the fourth quarter alone.